BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases, the foregoing featuring monoclonal antibodies
Pending · December 13, 2022 · 97715586 ·